Yilan Miao

Papers

Total Citations

H-Index

About

Dr. Yilan Miao is a pioneering researcher at the intersection of nanobiotechnology and infectious disease, whose work is redefining therapeutic strategies against drug-resistant pathogens. Her primary research areas include nanozyme-based robotics, antifungal drug delivery, and the development of intelligent, targeted antimicrobial systems. Dr. Miao’s most notable contribution is the conceptualization and engineering of a "nanozyme-based robotics approach" for targeting fungal infections, a breakthrough that directly addresses the World Health Organization’s designation of fungal pathogens as a top-priority global health threat. This innovative platform, detailed in her highly cited 2023 paper (48 citations), overcomes critical limitations of conventional antifungal therapy by enhancing drug efficacy at the infection site while simultaneously minimizing off-target toxicity, preventing fungal dissemination, and curbing the development of drug tolerance. By integrating catalytic nanozymes with responsive robotic mechanisms, her work offers a paradigm shift in how we combat invasive mycoses. With her research already garnering significant attention, Dr. Miao is establishing herself as a leading voice in the fight against antimicrobial resistance, laying the groundwork for next-generation, precision-guided nanotherapeutics.